H. Roth

发表

Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics

T. Fan, P. Hergenrother, Rachel C. Botham, 2016, ACS central science.

Derivatives of Procaspase-Activating Compound 1 (PAC-1) and Anticancer Activities

P. Hergenrother, H. Roth, 2016 .

N-heterocyclic carbene-catalyzed rearrangements of vinyl sulfones.

K. Scheidt, H. Roth, Roxanne L. Atienza, 2011, Chemical science.

NHC-catalyzed reactions of aryloxyacetaldehydes: a domino elimination/conjugate addition/acylation process for the synthesis of substituted coumarins.

K. Scheidt, A. Ott, H. Roth, 2009, Organic letters.

Synthesis of [5,6]-Bicyclic Heterocycles with a Ring-Junction Nitrogen Atom: Rhodium(III)-Catalyzed C-H Functionalization of Alkenyl Azoles.

J. Ellman, H. Roth, K. Halskov, 2017, Angewandte Chemie.

Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.

P. Hergenrother, H. Roth, 2016, Current medicinal chemistry.

Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients

Lisa J. Schlein, M. Podell, G. Riggins, 2017, Oncotarget.

Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).

P. Hergenrother, Rachel C. Botham, H. Roth, 2012, ACS combinatorial science.

The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas

T. Fan, P. Hergenrother, K. Wycislo, 2016, Molecular Cancer Therapeutics.

Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.

T. Fan, P. Hergenrother, Rachel C. Botham, 2015, Journal of medicinal chemistry.

NHC-catalyzed reactions of aryloxyacetaldehydes: a domino elimination/conjugate addition/acylation process for the synthesis of substituted coumarins.

K. Scheidt, A. Ott, H. Roth, 2009, Organic letters.